rs1344642

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015690.5(STK36):​c.1748G>A​(p.Arg583Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.437 in 1,612,946 control chromosomes in the GnomAD database, including 159,073 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R583W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.48 ( 18802 hom., cov: 32)
Exomes 𝑓: 0.43 ( 140271 hom. )

Consequence

STK36
NM_015690.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.78

Publications

60 publications found
Variant links:
Genes affected
STK36 (HGNC:17209): (serine/threonine kinase 36) This gene encodes a member of the serine/threonine kinase family of enzymes. This family member is similar to a Drosophila protein that plays a key role in the Hedgehog signaling pathway. This human protein is a positive regulator of the GLI zinc-finger transcription factors. Knockout studies of the homologous mouse gene suggest that defects in this human gene may lead to congenital hydrocephalus, possibly due to a functional defect in motile cilia. Because Hedgehog signaling is frequently activated in certain kinds of gastrointestinal cancers, it has been suggested that this gene is a target for the treatment of these cancers. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011]
STK36 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ciliary dyskinesia, primary, 46
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.5153664E-6).
BP6
Variant 2-218690539-G-A is Benign according to our data. Variant chr2-218690539-G-A is described in ClinVar as Benign. ClinVar VariationId is 403497.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.638 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STK36NM_015690.5 linkc.1748G>A p.Arg583Gln missense_variant Exon 14 of 27 ENST00000295709.8 NP_056505.2 Q9NRP7-1A0A140VJW1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STK36ENST00000295709.8 linkc.1748G>A p.Arg583Gln missense_variant Exon 14 of 27 1 NM_015690.5 ENSP00000295709.3 Q9NRP7-1

Frequencies

GnomAD3 genomes
AF:
0.482
AC:
73247
AN:
151902
Hom.:
18751
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.643
Gnomad AMI
AF:
0.350
Gnomad AMR
AF:
0.443
Gnomad ASJ
AF:
0.415
Gnomad EAS
AF:
0.138
Gnomad SAS
AF:
0.327
Gnomad FIN
AF:
0.437
Gnomad MID
AF:
0.404
Gnomad NFE
AF:
0.444
Gnomad OTH
AF:
0.457
GnomAD2 exomes
AF:
0.413
AC:
103838
AN:
251210
AF XY:
0.409
show subpopulations
Gnomad AFR exome
AF:
0.653
Gnomad AMR exome
AF:
0.402
Gnomad ASJ exome
AF:
0.405
Gnomad EAS exome
AF:
0.137
Gnomad FIN exome
AF:
0.445
Gnomad NFE exome
AF:
0.441
Gnomad OTH exome
AF:
0.434
GnomAD4 exome
AF:
0.432
AC:
631525
AN:
1460926
Hom.:
140271
Cov.:
37
AF XY:
0.428
AC XY:
311188
AN XY:
726824
show subpopulations
African (AFR)
AF:
0.658
AC:
22023
AN:
33460
American (AMR)
AF:
0.406
AC:
18140
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.410
AC:
10717
AN:
26128
East Asian (EAS)
AF:
0.129
AC:
5125
AN:
39688
South Asian (SAS)
AF:
0.337
AC:
29036
AN:
86236
European-Finnish (FIN)
AF:
0.441
AC:
23576
AN:
53414
Middle Eastern (MID)
AF:
0.387
AC:
2231
AN:
5764
European-Non Finnish (NFE)
AF:
0.445
AC:
494511
AN:
1111172
Other (OTH)
AF:
0.434
AC:
26166
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
16637
33275
49912
66550
83187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14878
29756
44634
59512
74390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.483
AC:
73359
AN:
152020
Hom.:
18802
Cov.:
32
AF XY:
0.475
AC XY:
35284
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.644
AC:
26695
AN:
41446
American (AMR)
AF:
0.443
AC:
6754
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.415
AC:
1439
AN:
3470
East Asian (EAS)
AF:
0.139
AC:
717
AN:
5164
South Asian (SAS)
AF:
0.328
AC:
1579
AN:
4816
European-Finnish (FIN)
AF:
0.437
AC:
4620
AN:
10566
Middle Eastern (MID)
AF:
0.408
AC:
119
AN:
292
European-Non Finnish (NFE)
AF:
0.444
AC:
30151
AN:
67984
Other (OTH)
AF:
0.457
AC:
966
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1856
3712
5567
7423
9279
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.447
Hom.:
52976
Bravo
AF:
0.492
TwinsUK
AF:
0.444
AC:
1645
ALSPAC
AF:
0.445
AC:
1714
ESP6500AA
AF:
0.636
AC:
2804
ESP6500EA
AF:
0.439
AC:
3775
ExAC
AF:
0.419
AC:
50909
Asia WGS
AF:
0.281
AC:
980
AN:
3478
EpiCase
AF:
0.442
EpiControl
AF:
0.444

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.13
T;.;T
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.79
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.77
.;T;T
MetaRNN
Benign
0.0000035
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.26
N;N;N
PhyloP100
1.8
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.74
N;N;N
REVEL
Benign
0.025
Sift
Benign
0.13
T;T;T
Sift4G
Benign
0.54
T;T;T
Polyphen
0.041
B;B;B
Vest4
0.087
MPC
0.20
ClinPred
0.0017
T
GERP RS
2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.039
gMVP
0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1344642; hg19: chr2-219555262; COSMIC: COSV55325134; COSMIC: COSV55325134; API